New weight-loss drugs show potential health benefits and risks, study finds

New research shows that weight-loss drugs like Ozempic and Wegovy may improve overall health, linking them to better heart health, reduced infections, and lower risks of substance abuse and dementia. However, they also pose risks, including increased joint pain and inflammation. The study analyzed data from about two million people, primarily US veterans with type 2 diabetes. It found significant health benefits, such as lower rates of heart attacks and strokes, but also noted digestive issues and other side effects. Researchers caution that the findings need careful interpretation. Most participants were white men, limiting the study's applicability. Further clinical trials are needed to confirm these results and understand the drugs' full impact on health.